MedonyX is a Jordan-based pharmaceutical, natural products, and medical device distribution company. We are building partnerships to support healthcare product access in Jordan, Iraq, and other key markets in the MENA region.
Local understanding. Responsible growth.
Founded in 2024, MedonyX is developing a focused distribution business serving healthcare markets in Jordan and Iraq. We aim to work with suppliers and local partners to bring relevant pharmaceutical, natural health, and medical device products to market responsibly.
Our approach is grounded in local market understanding, regulatory awareness, and professional experience across the pharmaceutical sector. As the company develops, we will share updates about our partnerships, product portfolio, and market activities.
What We Do
MedonyX is developing capabilities to support suppliers and healthcare partners with:
Understanding local market needs and identifying appropriate opportunities.
Supporting product-related regulatory processes in coordination with suppliers and qualified local partners, as applicable.
Developing practical distribution arrangements suited to each product and market.
Building clear, professional working relationships with manufacturers, distributors, and other healthcare stakeholders.
We welcome inquiries from pharmaceutical, natural health, and medical device companies interested in discussing potential opportunities in Jordan and Iraq and other key markets in the MENA region.
Leadership
Our Initial Markets
MedonyX is initially focused on Jordan and Iraq. Our longer-term ambition is to explore opportunities in other markets, including the ,UAE and Gulf countries, subject to business development, regulatory requirements, and suitable partnerships.
Launch is expected in
MedonyX × Enzymatica
Medonyx and Enzymatica have entered into a long-term exclusive distribution agreement for ColdZyme® in Jordan and Iraq—marking Enzymatica’s entry into the MENA region. With support from MMDS’s regional platform, Medonyx will work to support the product’s launch and growth in both markets.
Warm thanks to Dr. Amer Al-Mokbel and Dr. Lina S. Al-Momani. We look forward to what we’ll build together.
#ColdZyme #Enzymatica #Medonyx #Jordan #Iraq #ConsumerHealth #Partnership
Before publishing: Confirm Enzymatica’s approval of the website wording, the exact company styling (“Medonyx” or “MedonyX Co.”), and permission to use the ColdZyme® and Enzymatica names and logos.